![](/img/cover-not-exists.png)
P390 Re-introduction of infliximab after consecutive failure of infliximab and adalimumab is beneficial in refractory Crohn's disease
Brandse, J.F., Peters, C.P., Eshuis, E.J., Lowenberg, M., Ponsioen, C.Y., van den Brink, G.R., D'Haens, G.R.A.M.Volume:
7
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1016/S1873-9946(13)60411-0
Date:
February, 2013
File:
PDF, 116 KB
english, 2013